Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment-Reference-Cited by-同舟云学术

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

Published:2015-05-25 Issue:36 Volume:36 Page:2425-2437
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:Eur Heart J

Author:

Wiegman Albert,Gidding Samuel S.,Watts Gerald F.,Chapman M. John,Ginsberg Henry N.,Cuchel Marina,Ose Leiv,Averna Maurizio,Boileau Catherine,Borén Jan,Bruckert Eric,Catapano Alberico L.,Defesche Joep C.,Descamps Olivier S.,Hegele Robert A.,Hovingh G. Kees,Humphries Steve E.,Kovanen Petri T.,Kuivenhoven Jan Albert,Masana Luis,Nordestgaard Børge G.,Pajukanta Päivi,Parhofer Klaus G.,Raal Frederick J.,Ray Kausik K.,Santos Raul D.,Stalenhoef Anton F.H.,Steinhagen- Thiessen Elisabeth,Stroes Erik S.,Taskinen Marja-Riitta,Tybjærg-Hansen Anne,Wiklund Olov

Funder

Amgen, Aegerion, AstraZeneca, Genzyme, Hoffman-La Roche, Kowa Europe, Novartis, and Sanofi-Aventis/Regeneron

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/36/36/2425/7110494/ehv157.pdf

Reference140 articles.

1. A Receptor-Mediated Pathway for Cholesterol Homeostasis

2. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome

3. Prenatal diagnosis of homozygous familial hypercholesterolaemia. Expression of a genetic receptor disease in utero;Brown;Lancet,1978